BSE filing, NSE: DPWIRES. Summary written from the filing by ALFA Finder's alert engine.
D P Wires Ltd: key numbers
- Share price
- ₹181.40
- Market cap
- ₹281.2 Cr
- Revenue (annual)
- ₹480.1 Cr
- Net profit (annual)
- ₹17.58 Cr
- P/E (TTM)
- 15.0×Sector 16.7×
- Promoter holding
- 74.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from D P Wires Ltd
All →D P Wires Other Announcement
D.P. Wires Ltd submitted its quarterly shareholding pattern as per Regulation 31(1)(b) of the SEBI (LODR) Regulations for the period ended September 30, 2026.
D P Wires Price Movement Clarification
D.P. Wires Ltd clarified that recent share price movements are purely market-driven, and no undisclosed material information exists that could affect the security's price.
D P Wires Annual General Meeting
D.P. Wires Ltd held its 28th Annual General Meeting on September 30, 2026, discussing financial statements and other routine business resolutions.
D P Wires Annual Report
D.P. Wires Ltd submitted its Annual Report for FY 2025-26 along with the 28th AGM notice scheduled for September 30, 2026. No new financial or business event is disclosed in this filing.
D P Wires Annual General Meeting
D.P. Wires Ltd has issued a notice for its 28th Annual General Meeting scheduled for September 30, 2026, to transact ordinary and special business.
D P Wires Board Meeting Outcome
DP Wires Ltd approved its Board Report, Corporate Governance Report, and notice for the 28th Annual General Meeting scheduled for September 30, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.